Mfgr's of Aug 12th, 2024: Phase II study that w
Post# of 148101
(Total Views: 550)
Posted On: 08/29/2024 5:51:39 PM
Mfgr's of Aug 12th, 2024:
Phase II study that will investigate the preliminary safety and activity of leronlimab in combination with trifluridine plus tipiracil (TAS-102) and bevacizumab
_____
* Sandoz and Monarch Pharma are generic manufacturers of trifluridine
*Trifluridine is also an ingredient in the oral anti-cancer drug trifluridine/tipiracil, which is sold under the brand name Lonsurf.
_____
Bevacizumab
*Amneal Pharmaceuticals, Inc. is a manufacturer of a biosimilar version of bevacizumab, called ALYMSYS (bevacizumab-maly).
______
Largest generic manufacturer:
Teva Pharmaceutical
Phase II study that will investigate the preliminary safety and activity of leronlimab in combination with trifluridine plus tipiracil (TAS-102) and bevacizumab
_____
* Sandoz and Monarch Pharma are generic manufacturers of trifluridine
*Trifluridine is also an ingredient in the oral anti-cancer drug trifluridine/tipiracil, which is sold under the brand name Lonsurf.
_____
Bevacizumab
*Amneal Pharmaceuticals, Inc. is a manufacturer of a biosimilar version of bevacizumab, called ALYMSYS (bevacizumab-maly).
______
Largest generic manufacturer:
Teva Pharmaceutical
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼